Complete Filing Data
NewGenIvf Group Ltd reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents of $758.6 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NewGenIvf Group Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | $9.9M | -$524.6K | $130.2K | $458.7K | -$533.00 |
| Selling And Marketing Expense | $1.2M | $206.3K | $18.0K | $36.2K | $24.7K |
| Revenues | $4.7M | $5.4M | $5.1M | $5.9M | $4.1M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$222.9K | $32.5K | -$22.7K | -$1.9K | $7.8K |
| Operating Income Loss | -$10.7M | -$1.2M | $42.2K | $398.7K | $198.8K |
| Operating Expenses | $11.7M | $3.0M | $1.6M | $1.1M | $826.0K |
| Nonoperating Income Expense | $20.5M | $199.7K | $66.2K | -$54.7K | -$42.6K |
| Net Income Loss Attributable To Noncontrolling Interest | -$150.7K | $50.5K | -$21.8K | -$322.8K | -$138.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $9.7M | -$960.8K | $108.4K | $344.0K | $156.2K |
| Gross Profit | $955.8K | $1.8M | $1.7M | $1.5M | $1.0M |
| General And Administrative Expense | $10.5M | $2.8M | $1.6M | $1.1M | $801.3K |
| Cost Of Revenue | $3.8M | $3.6M | $3.5M | $4.4M | $3.1M |
| Comprehensive Income Net Of Tax | $9.5M | -$441.6K | $85.7K | $133.9K | $5.6K |
| Income Tax Expense Benefit | -$486.7K | $208.1K | $294.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $26.6M | -$1.0M | $3.7M | $563.1K | -$914.9K | -$984.1K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $758.6K | $457.7K | $54.1K | $27.6K | $28.8K | $106.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $506.9K | $358.7K | $45.5K | -$17.3K | -$127.9K | |
| Finance Lease Principal Payments | $6.4K | $9.3K | $19.5K | $17.2K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $311.4K | $186.8K | $198.5K | $203.4K | $175.8K | |
| Assets Noncurrent | $25.3M | $405.0K | $2.0M | $506.3K | $592.4K | |
| Property Plant And Equipment Net | $1.8M | $273.1K | $162.2K | $122.7K | ||
| Operating Lease Right Of Use Asset | $504.2K | $98.6K | $283.8K | $383.7K | ||
| Operating Lease Liability Noncurrent | $272.4K | $10.2K | $119.0K | $242.2K | ||
| Operating Lease Liability Current | $238.1K | $108.5K | $207.1K | $184.7K | ||
| Inventory Net | $335.4K | $80.8K | $126.3K | $46.9K | ||
| Accounts Receivable Net Current | $166.5K | $49.2K | $9.4K | $13.0K | ||
| Accounts Payable And Other Accrued Liabilities Current | $711.9K | $500.7K | $241.6K | $289.8K | ||
| Retained Earnings Accumulated Deficit | $8.9M | -$986.0K | -$461.4K | -$591.5K | ||
| Minority Interest | -$644.8K | -$433.1K | -$490.1K | -$462.4K | ||
| Liabilities Noncurrent | $4.4M | $2.3M | $119.0K | $248.6K | ||
| Liabilities Current | $2.4M | $2.7M | $1.1M | $2.6M | ||
| Liabilities And Stockholders Equity | $32.7M | $3.6M | $4.5M | $2.9M | ||
| Liabilities | $6.7M | $5.1M | $1.2M | $2.8M | ||
| Contract With Customer Liability Current | $112.0K | $63.5K | $7.9K | $1.4M | ||
| Cash And Cash Equivalents At Carrying Value | $758.6K | $457.7K | $54.1K | $27.6K | ||
| Assets Current | $7.4M | $3.2M | $2.5M | $2.4M | ||
| Assets | $32.7M | $3.6M | $4.5M | $2.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$143.1K | $18.9K | -$7.3K | $9.6K | ||
| Accounts Payable Current | $779.3K | $1.3M | $172.6K | $104.7K | ||
| Prepaid Expense And Other Assets Current | $195.4K | $512.6K | $70.3K | |||
| Taxes Payable Current | $11.7K | $486.7K | $486.9K | |||
| Stockholders Equity Note Subscriptions Receivable | $204.0K | $127.6K | $319.9K | |||
| Stock Issued During Period Value Settlement Of Subscription Receivable | $127.6K | $192.3K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Repayments Of Related Party Debt | -$148.0K | $508.7K | $1.9M | -$1.7M | -$2.0M |
| Net Cash Provided By Used In Operating Activities | -$10.9M | -$8.3M | -$1.8M | $1.7M | $1.4M |
| Net Cash Provided By Used In Financing Activities | $19.0M | $8.7M | $1.9M | -$1.6M | -$1.5M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $211.2K | -$6.8M | -$51.2K | $190.7K | $79.9K |
| Increase Decrease In Inventories | $254.5K | -$45.5K | $80.7K | $7.2K | -$1.4K |
| Increase Decrease In Contract With Customer Liability | $48.5K | $55.6K | -$1.4M | $548.0K | $812.2K |
| Increase Decrease In Accounts Receivable | $117.3K | $39.9K | -$1.2K | -$129.9K | -$56.2K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$206.0K | $45.0K | -$19.0K | $16.1K | $50.5K |
| Payments To Acquire Property Plant And Equipment | $135.0K | $53.0K | $69.8K | $94.5K | $16.6K |
| Net Cash Provided By Used In Investing Activities | -$7.6M | -$53.0K | -$69.8K | -$94.5K | -$16.6K |
| Increase Decrease In Operating Lease Liability | -$204.8K | -$230.4K | -$175.1K | -$148.7K | |
| Increase Decrease In Accounts Payable | -$519.7K | $1.1M | $71.4K | $58.8K | -$61.0K |
| Depreciation Depletion And Amortization | $188.1K | $19.5K | $31.2K | $100.5K | $166.7K |
| Increase Decrease In Other Receivables | $110.4K | $2.0M | $448.3K | $15.2K | -$11.0K |
| Increase Decrease In Accrued Income Taxes Payable | -$11.7K | $11.7K | -$12.2K | $290.9K | |
| Proceeds From Issuance Of Other Long Term Debt | $6.8M | $8.6M | $128.2K | $512.8K | |
| Increase Decrease In Finance Receivables | $321.9K | $204.8K | $230.4K | $19.5K | $19.5K |
| Proceeds From Amount Due From ASPACI | -$140.0K | $140.0K | |||
| Share Based Compensation | $240.0K | $200.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 46.0K | 119.00 | 10.00 | 28.8K | 560.0K |
| Earnings Per Share Basic | $214.73 | $-4,408.76 | $13,019.30 | $4.72 | $0.00 |
| Weighted Average Number Of Diluted Shares Outstanding | 3.3M | 119.00 | 10.00 | 28.8K | 560.0K |
| Earnings Per Share Diluted | $3.04 | $-4,408.76 | $13,019.30 | $4.72 | $0.00 |
| Common Stock Shares Issued | 240.6K | 380.00 | 507.5K | 601.8K | |
| Common Stock Shares Outstanding | 240.6K | 380.00 | 507.5K | 601.8K | |
| Common Stock Shares Authorized | 10.0M | 10.0M | 5.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Interest Paid Net | $26.2K | $677.7K | $24.7K | $55.5K | $65.6K |
| Other Income | -$8.1K | $971.4K | $111.8K | $23.0K | $45.7K |
| Investment Income Investment Expense | $616.4K | $778.7K | $46.2K | $77.8K | $88.3K |
| Investment Income Interest | $2.3K | $7.0K | $518.00 | $21.00 | $63.00 |
| Provision For Other Credit Losses | $625.00 | $10.8K | $6.7K | ||
| Additional Paid In Capital | $17.9M | $122.5K | $4.3M | $1.5M | |
| Paymentof Interest | $26.2K | $677.7K | $24.7K | ||
| Stock Issued During Period Value New Issues | $2.9M | $641.7K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.